Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years.
William John YaxleyJames MackeanDevang J DesaiGail TsangJudi DixonHemamali SamaratungaBrett DelahuntLars EgevadRobert A GardinerJohn William YaxleyPublished in: BJU international (2022)
LDRBT is associated with excellent PCSS, with a median follow-up of 11.8 years. The risk of post-implantation urethral stricture and UI is low and a pre-implantation BNI for management of bladder outflow obstruction does not increase the risk of UI or urethral stricture.